Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link. All three major indices are trading down today with the Dow Jones Industrial Average ( ^DJI) trading down 125 points (-0.7%) at 16,959 as of Friday, July 25, 2014, 12:55 PM ET. The NYSE advances/declines ratio sits at 982 issues advancing vs. 1,968 declining with 163 unchanged. The Health Services industry currently sits down 0.4% versus the S&P 500, which is down 0.5%. Top gainers within the industry include Tenet Healthcare ( THC), up 6.0%, and Grifols ( GRFS), up 0.9%. On the negative front, top decliners within the industry include WellCare Health Plans ( WCG), down 20.3%, Centene ( CNC), down 6.5%, Intuitive Surgical ( ISRG), down 1.8%, Boston Scientific ( BSX), down 1.5% and UnitedHealth Group ( UNH), down 1.2%. TheStreet would like to highlight 3 stocks pushing the industry higher today: 3. Align Technology ( ALGN) is one of the companies pushing the Health Services industry higher today. As of noon trading, Align Technology is up $3.20 (6.0%) to $56.43 on heavy volume. Thus far, 1.0 million shares of Align Technology exchanged hands as compared to its average daily volume of 1.1 million shares. The stock has ranged in price between $55.00-$56.86 after having opened the day at $55.77 as compared to the previous trading day's close of $53.23. Align Technology, Inc. operates as a medical device company primarily in the United States and internationally. Align Technology has a market cap of $4.3 billion and is part of the health care sector. Shares are down 6.8% year-to-date as of the close of trading on Thursday. Currently there are 6 analysts who rate Align Technology a buy, no analysts rate it a sell, and 3 rate it a hold. TheStreet Ratings rates Align Technology as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity, expanding profit margins and good cash flow from operations. We feel these strengths outweigh the fact that the company is trading at a premium valuation based on our review of its current price compared to such things as earnings and book value. Get the full Align Technology Ratings Report now. 3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.